in page functions

29 June 2007

Independent Expert Committee Recommendation for AMC Pilot

The Independent Expert Committee was convened to assess which of the six vaccines included in the Tremonti report would be most suitable for the pilot AMC.

11 March 2007

EEG Donor response

In May 2007, the AMC Donor Committee constituted an independent Economic Expert Group (EEG) to advise on the initial AMC design. This document is the donors' response to the EEG report.

09 February 2007

IFPMA Press Release in support of AMC Launch

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) welcomes the public commitment made by the governments of Canada, Italy, Norway and the United Kingdom to fund the pilot Advance Market Commitment (AMC) to stimulate the development of new pneumococcal vaccines for the poorest countries.

09 February 2007

Remarks by Her Majesty Queen Rania of Jordan on the AMC Launch 2007

Remarks of Her Majesty Queen Rania Al-Abdullah on the announcement of Advanced Market Commitments of $1.5 billion in Rome, Italy on 9 February 2007.

09 February 2007

Bill and Melinda Gates Foundation - Statement of Support

Statement from the Bill and Melinda Gates foundation announcing support for the pneumococcal AMC.

09 February 2007

Pope Address at Vaccine Project Launch

The address Pope Benedict XVI gave to the representatives of the Advance Market Commitment in Rome, Italy on 9 February 2007.

08 February 2007

Pneumococcal Disease - The Human Face

Stories of three young children in Africa and Asia and their fight against pneumococcal disease.

08 February 2007

Pneumococcal Disease Background

Streptococcus pneumoniae are bacteria that are frequently found in the upper respiratory tract of healthy children and adults. These bacteria, however, can also cause a range of infections – from relatively mild ear infections to fatal pneumonia, meningitis, and sepsis. Serious pneumococcal infections can occur throughout life, but children under two years old and the elderly are at highest risk. 

09 November 2006

Second Donor Working Group - Framework

Framework document for the pilot AMC for pneumococcal vaccines.

09 November 2006

Second Donor Working Group - Participants London, November 2006

List of participants at the 2nd meeting of the AMC working group.

09 November 2006

Second Donor Working Group - Agenda London, November 2006

Agenda of the second meeting of the Technical Working Group in London on 9 November 2006.

09 November 2006

Second Donor Working Group - Summary London, November 2006

Summary of the second meeting of the Technical Working Group on AMC held in London on 9 November 2006.

07 September 2006

First Donor Working Group - Summary Rome, 7 September 2006

Summary of the first meeting of the Technical Working Group on AMC held in Rome on 7 September 2006.

07 September 2006

Pilot Proposal

Pilot proposal for the Advance Market Committment to demonstrate both the feasability of the AMC mechanism and its impact on accelerating vaccine development, production scale-up and introduction.

28 February 2006

Independent Expert Committee Membership

List of members of the Indepedent Expert Committee meeting in Paris, France held the 27-28 February 2008.

02 December 2005

Tremonti Report to the G8 Finance Ministers

Background papers to the AMC providing the analysis underpinning Minister Giulio Tremonti's Report to the G8 Finance Ministers Advanced Market Commitments to Vaccines.

11 March 2005

Making markets for vaccines: Ideas to action

This report discusses the need to invest more in vaccines and the proposal of making a commitment in advance to buy vaccines if and when they are developed to create incentives for industry to increase investment in research and development.


close icon

modal window here